Multi-target novel neuroprotective compound ITH33/IQM9.21 inhibits calcium entry, calcium signals and exocytosis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cell Calcium

• Publication date

  2011-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ceca.2011.06.006PMID 21839513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's disease

  2013cited by this paper
• Loss of Cav1.3 Channels Reveals the Critical Role of L-Type and BK Channel Coupling in Pacemaking Mouse Adrenal Chromaffin Cells

  2010cited by this paper
• Blockade by Nanomolar Resveratrol of Quantal Catecholamine Release in Chromaffin Cells

  2010cited by this paper
• Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives.

  2010cited by this paper
• Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease.

  2009cited by this paper
• Differences in the quantal release of catecholamines in chromaffin cells of rat embryos and their mothers.

  2009cited by this paper
• Apoptotic mechanisms after cerebral ischemia.

  2009cited by this paper
• Alzheimer's disease: new approaches to drug discovery.

  2009cited by this paper
• Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease.

  2009cited by this paper
• Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials.

  2009cited by this paper
• Tacrine–Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties

  2009cited by this paper
• Differential variations in Ca2+ entry, cytosolic Ca2+ and membrane capacitance upon steady or action potential depolarizing stimulation of bovine chromaffin cells

  2008cited by this paper
• Good practices in single-cell amperometry.

  2008cited by this paper
• Multi-target-directed ligands to combat neurodegenerative diseases.

  2008cited by this paper
• The Past and Future of Neuroprotection in Cerebral Ischaemic Stroke

  2007cited by this paper
• Calcium signaling and exocytosis in adrenal chromaffin cells.

  2006cited by this paper
• Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders.

  2005cited by this paper
• Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance.

  2005cited by this paper
• Pathophysiology of Stroke: Lessons from Animal Models

  2004cited by this paper
• Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase bcl-2 expression after focal cerebral ischemia.

  2003cited by this paper
• Acetylcholine and potassium elicit different patterns of exocytosis in chromaffin cells when the intracellular calcium handling is disturbed

  2002cited by this paper
• Nimodipine in Animal Model Experiments of Focal Cerebral Ischemia: A Systematic Review

  2001cited by this paper
• The versatility and universality of calcium signalling

  2000cited by this paper
• Chromaffin-cell stimulation triggers fast millimolar mitochondrial Ca 2+ transients

  2000cited by this paper
• Chromaffin-cell stimulation triggers fast millimolar mitochondrial Ca2+ transients that modulate secretion

  2000cited by this paper
• Activation of BK channels in rat chromaffin cells requires summation of Ca(2+) influx from multiple Ca(2+) channels.

  2000cited by this paper
• Pathobiology of ischaemic stroke: an integrated view.

  1999cited by this paper
• Calcium - a life and death signal

  1998cited by this paper
• Distinct effects of omega-toxins and various groups of Ca(2+)-entry inhibitors on nicotinic acetylcholine receptor and Ca2+ channels of chromaffin cells.

  1997cited by this paper
• Altered Na(+)-channel function as an in vitro model of the ischemic penumbra: action of lubeluzole and other neuroprotective drugs.

  1997cited by this paper
• Differential effects of the neuroprotectant lubeluzole on bovine and mouse chromaffin cell calcium channel subtypes

  1997cited by this paper
• Dominant role of mitochondria in clearance of large Ca2+ loads from rat adrenal chromaffin cells.

  1996cited by this paper
• Ischemia-induced neuronal apoptosis.

  1996cited by this paper
• Contribution of SK and BK channels in the control of catecholamine release by electrical stimulation of the cat adrenal gland.

  1995cited by this paper
• Calcium‐mediated cell injury and cell death

  1995cited by this paper
• Reduction of infarct size by intra-arterial nimodipine administered at reperfusion in a rat model of partially reversible brain focal ischemia.

  1995cited by this paper
• Calcium regulation of gene expression in neuronal cells.

  1994cited by this paper
• R56865 inhibits catecholamine release from bovine chromaffin cells by blocking calcium channels

  1993cited by this paper
• Small-conductance Ca2+-activated K+ channels in bovine chromaffin cells

  1993cited by this paper
• Suppression of programmed neuronal death by sustained elevation of cytoplasmic calcium

  1992cited by this paper
• Suppression of programmed neuronal death by sustained elevation of cytoplasmic calcium.

  1992cited by this paper
• Rapid changes of mitochondrial Ca2+ revealed by specifically targeted recombinant aequorin

  1992cited by this paper
• Temporally resolved catecholamine spikes correspond to single vesicle release from individual chromaffin cells.

  1991cited by this paper
• Separation and culture of living adrenaline- and noradrenaline-containing cells from bovine adrenal medullae.

  1990cited by this paper
• Ca2+-mediated neuronal death in rat brain neuronal cultures by veratridine: protection by flunarizine.

  1989cited by this paper
• Role of Ca2+ channels in the ability of membrane depolarization to prevent neuronal death induced by trophic-factor deprivation: evidence that levels of internal Ca2+ determine nerve growth factor dependence of sympathetic ganglion cells.

  1989cited by this paper
• Adrenal medullary chromaffin cells in vitro.

  1984cited by this paper
• Consequences of uncontrolled calcium entry and its prevention with calcium antagonists.

  1983cited by this paper
• Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

  1981cited by this paper
• Ca-dependent K channels with large unitary conductance in chromaffin cell membranes

  1981cited by this paper
• Agonist-induced myopathy at the neuromuscular junction is mediated by calcium

  1979cited by this paper
• Calcium dependence of toxic cell death: a final common pathway.

  1979cited by this paper
• Separation of two voltage‐sensitive potassium currents, and demonstration of a tetrodotoxin‐resistant calcium current in frog motoneurones.

  1976cited by this paper
• The effect of calcium on acetylcholine release from motor nerve terminals

  1965cited by this paper

• Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment

  2024cites this paper
• Alignment-independent 3D-QSAR and molecular docking studies of tacrine-4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents

  2019cites this paper
• Profiling donepezil template into multipotent hybrids with antioxidant properties

  2018cites this paper
• New Therapeutic Strategy for the Neurodegenerative Diseases: Pharmacological Modulation of Ca2+/Camp Signaling Interaction

  2018cites this paper
• Pharmacological modulation of neural Ca2+/camp signaling interaction as therapeutic goal for treatment of Alzheimer´s disease

  2017cites this paper
• NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage

  2017cites this paper
• Advances for The pharmacotherapy of Alzheimer ́s Disease: The Ca2+/cAMP Signaling Interaction

  2017cites this paper
• Novel therapeutics from old pharmaceuticals: The Ca/cAMP signaling interaction as a new pharmaceutical target for treatment of diseases related to aging

  2017cites this paper
• Enzymatic and solid-phase synthesis of new donepezil-based L- and d-glutamic acid derivatives and their pharmacological evaluation in models related to Alzheimer's disease and cerebral ischemia.

  2017cites this paper
• A Novel Therapeutic Target for Treatment of Alzheimer ’ s Disease : The Ca 2 + / cAMP Signalling Interaction

  2017cites this paper
• New Therapeutic Perspectives for the Cognitive Deficit in Alzheimer's Disease: Pharmacological Modulation of Ca2+/cAMP Signaling Interaction

  2017cites this paper
• Challenges for the Pharmacological Treatment of Dementia : Implications of the Ca 2 + / cAMP Intracellular Signalling Interaction

  2016cites this paper
• Neuroprotective Effect of the Novel Compound ITH33/IQM9.21 Against Oxidative Stress and Na+ and Ca2+ Overload in Motor Neuron-like NSC-34 Cells

  2016cites this paper
• Challenges for the pharmacological treatment of neurological and psychiatric disorders: Implications of the Ca(2+)/cAMP intracellular signalling interaction.

  2016cites this paper
• ITH33/IQM9.21 provides neuroprotection in a novel ALS model based on TDP-43 and Na+/Ca2+ overload induced by VTD.

  2016cites this paper
• Pharmacological implications of the Ca2+/cAMP signaling interaction: from risk for antihypertensive therapy to potential beneficial for neurological and psychiatric disorders

  2015cites this paper
• Blockade by NNC 55-0396, mibefradil, and nickel of calcium and exocytotic signals in chromaffin cells: implications for the regulation of hypoxia-induced secretion at early life.

  2015cites this paper
• Dibenzo[1,4,5]thiadiazepine: a hardly-known heterocyclic system with neuroprotective properties of potential usefulness in the treatment of neurodegenerative diseases.

  2014cites this paper
• Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemia.

  2013cites this paper
• Multitarget Drugs for Stabilization of Calcium Cycling and Neuroprotection in Neurodegenerative Diseases and Stroke

  2012cites this paper
• Stabilizers of neuronal and mitochondrial calcium cycling as a strategy for developing a medicine for Alzheimer's disease.

  2012cites this paper
• New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.

  2012cites this paper
• CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: protection by resveratrol but not riluzole.

  2011cites this paper